Blog
RSS FeedPosted by Michael Wonder on 14 Sep 2019
U.S. officials worried about Chinese control of American drug supply
13 September 2019 - "Basically we've outsourced our entire industry to China," retired Brig. Gen. John Adams told NBC News. "That ...
Posted by Michael Wonder on 12 Sep 2019
China’s grip on pharmaceutical drugs is a national security issue
10 September 2019 - If you take a pill every day to treat high blood pressure or high cholesterol, you ...
Posted by Michael Wonder on 05 Sep 2019
Tagrisso approved in China as a first-line treatment for EGFR-mutated non-small cell lung cancer
4 September 2019 - In the Phase III FLAURA trial, Tagrisso significantly increased the time patients lived without disease progression ...
Posted by Michael Wonder on 02 Sep 2019
China expands drug bulk-buy program, puts pressure on pharma firms
2 September 2019 - China has expanded a pilot drug bulk-buying program to almost the entire country in an attempt ...
Posted by Michael Wonder on 27 Aug 2019
China eases rules on cheap drug imports to fight chronic diseases
27 August 2019 - China said it would reduce the penalties for the sale and import of unapproved drugs, effectively ...
Posted by Michael Wonder on 26 Aug 2019
China loosens curbs on small, unapproved drug imports
26 August 2019 - China said on Monday it was relaxing drug laws to give greater leniency to people who ...
Posted by Michael Wonder on 26 Aug 2019
China revises law to ensure drug safety
26 August 2019 - China's top legislature on Monday voted to adopt the revision to the drug administration law as ...
Posted by Michael Wonder on 24 Aug 2019
China vows to maintain stable drug prices
22 August 2019 - Chinese authorities vowed to take actions to make sure the drug prices are set reasonably by ...
Posted by Michael Wonder on 22 Aug 2019
Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease
22 August 2019 - China becomes the first country to approve roxadustat for all chronic kidney disease patients with anaemia ...
Posted by Michael Wonder on 20 Aug 2019
China adds 148 drugs to key insurance list
20 August 2019 - China on Tuesday added 148 drugs to its list of medicines covered by basic medical insurance ...
Posted by Michael Wonder on 12 Aug 2019
China National Medical Products Administration approves Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) for treatment of HIV-1 infection
9 August 2019 - Biktarvy demonstrated high efficacy and a high barrier to resistance in clinical trials through 48 weeks. ...
Posted by Michael Wonder on 05 Aug 2019
China increases drug price control measures
5 August 2019 - From 1996, the Chinese government has adopted more than 30 price control strategies in an attempt to ...
Posted by Michael Wonder on 24 Jul 2019
U.S. dependence on China for medicine is a major problem
21 July 2019 - As tensions with China have escalated over the past year, Washington, D.C., is finally waking up ...
Posted by Michael Wonder on 23 Jul 2019
UCB announces approval of Cimzia in China
22 July 2019 - After receiving priority review in 2018, Cimzia (certolizumab pegol) is now approved in China for the treatment ...
Posted by Michael Wonder on 22 Jul 2019
Novartis key multiple sclerosis product Gilenya approved in China
19 July 2019 - Chinese National Medical Products Administration (NMPA) approved Gilenya for relapsing forms of multiple sclerosis for adults and ...